weight loss

مستقر49 خبر16 مصادرآخر تحديث: 1 sa önce

وسوم ذات صلةEli Lilly Wegovy Ozempic Mounjaro diet obesity retatrutide GLP-1

أحدث الأخبار

Senior doctors warn against unapproved weight loss drug retatrutide after liver damage cases

Senior doctors in Melbourne are warning the public against taking unapproved weight loss medication labelled as retatrutide, after multiple cases of severe liver damage and other illnesses were discovered. The injectable drug, not approved by any global regulator, is being sold on the black market, with one woman hospitalised in acute liver failure after just two doses.

ABC Top Stories

مُلِح

صحة·1 sa önceملخص الذكاء الاصطناعي

Senior doctors warn against unapproved 'retatrutide' weight loss drug after liver damage cases

Senior doctors in Melbourne are warning the public against using an unapproved weight loss drug labeled as retatrutide, after multiple cases of severe liver damage and other serious illnesses were reported. The injectable medication, not approved by any global drug regulator, is being sold on the black market.

ABC Top Stories

FDA considering tighter controls on GLP-1 weight loss drugs amid illegal imports

يتطور

صحة·6 sa önceملخص الذكاء الاصطناعي

FDA considering tighter controls on GLP-1 weight loss drugs amid illegal imports

The Food and Drug Administration (FDA) is considering stricter border controls for GLP-1 weight loss drugs due to illegal imports from China and online platforms. The agency is also proposing amendments to the Pharmaceutical Affairs Act to hold online platforms accountable for hosting illegal drug sales.

自

自由时报

UK Startup to Trial Cancer Drug to Prevent Life-Threatening Side-Effect

يتطور

صحة·5 g önceملخص الذكاء الاصطناعي

UK Startup to Trial Cancer Drug to Prevent Life-Threatening Side-Effect

Poolbeg Pharma will trial its oral drug POLB 001 at six NHS hospitals to prevent cytokine release syndrome (CRS), a dangerous side-effect of cancer immunotherapy. The drug could improve patient safety and save healthcare systems millions by allowing treatment outside specialist centers.

Guardian UK

Nutritionist Warns Against Excessive Protein Intake for Weight Loss and Muscle Gain

صحة

6 g önceملخص الذكاء الاصطناعي

Nutritionist Warns Against Excessive Protein Intake for Weight Loss and Muscle Gain

A nutritionist advises that excessive protein intake, especially when combined with insufficient vegetables and carbohydrates, can hinder metabolism, lead to fat accumulation, and cause fatigue, constipation, and thirst. She recommends balanced meals with plant-based proteins and complex carbohydrates for sustainable weight loss and muscle gain.

自

自由时报

Drug Repurposing: From Diabetes to Weight Loss and Beyond

يتطور

صحة·11.06.2026ملخص الذكاء الاصطناعي

Drug Repurposing: From Diabetes to Weight Loss and Beyond

The article explores drug repurposing, highlighting GLP-1 agonists like Ozempic and Wegovy, initially for diabetes, now used for weight loss, cardiovascular health, and more. It also discusses COVID-19 treatments like dexamethasone and baricitinib, and historical examples like raloxifene, thalidomide, BCG vaccine, and Viagra, emphasizing both the benefits and potential risks of using drugs for unapproved conditions.

Deutsche Welle

Chest pain: Heart or muscle? Honey in tea benefits, and gut bacteria for weight loss

صحة

11.06.2026ملخص الذكاء الاصطناعي

Chest pain: Heart or muscle? Honey in tea benefits, and gut bacteria for weight loss

This report covers three health topics: distinguishing chest pain from heart issues vs. muscle strain, the benefits of adding honey to tea, and a study on gut bacteria aiding long-term weight maintenance.

الشرق الأوسط

FDA Warns of Kidney Risks Linked to GSK's Alli Weight Loss Pill

مُلِح

صحة·11.06.2026ملخص الذكاء الاصطناعي

FDA Warns of Kidney Risks Linked to GSK's Alli Weight Loss Pill

US regulators are warning consumers about potential kidney problems linked to GSK's Alli weight loss pill. The FDA identified 12 cases of kidney complications and advises those with kidney history to consult a doctor.

The Independent World

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

صحة

11.06.2026ملخص الذكاء الاصطناعي

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

The UK's MHRA has approved the first GLP-1 receptor agonist tablet, semaglutide (Wegovy), for weight loss and management. This daily pill offers a more convenient alternative to weekly injections for adults with obesity or those overweight with weight-related conditions.

Times of India

GLP-1 Obesity Treatments Show Promise in Reducing Cancer Risk

صحة

10.06.2026ملخص الذكاء الاصطناعي

GLP-1 Obesity Treatments Show Promise in Reducing Cancer Risk

Recent studies suggest GLP-1 obesity treatments may reduce cancer risk, showing correlation with decreased incidence in 6 out of 7 cancers, potentially through anti-inflammatory effects beyond weight loss.

NPR News

Debunking the 'Toxic' Sugar Myth: A Dietitian's Perspective

صحة

08.06.2026ملخص الذكاء الاصطناعي

Debunking the 'Toxic' Sugar Myth: A Dietitian's Perspective

Dr. Emily Leeming clarifies that sugar itself isn't inherently harmful but rather the context in which it's consumed, highlighting the importance of overall diet quality and distinguishing between added 'free sugars' and natural sugars in whole foods.

Guardian International

Reddit User Shares 70-Pound Weight Loss Lessons, Highlighting Common Mistakes

صحة

04.06.2026ملخص الذكاء الاصطناعي

Reddit User Shares 70-Pound Weight Loss Lessons, Highlighting Common Mistakes

A Reddit user lost nearly 70 pounds by avoiding common weight-loss pitfalls like extreme restriction and guilt. They emphasize realistic eating, addressing emotional hunger, consistent exercise, and recovering quickly from setbacks.

Times of India

Experts Warn Against Extreme Weight Loss Methods, Emphasize Muscle Preservation

صحة

03.06.2026ملخص الذكاء الاصطناعي

Experts Warn Against Extreme Weight Loss Methods, Emphasize Muscle Preservation

Chinese health experts caution against extreme weight loss trends like "carb face" and "lying flat weight loss" injections. They stress that healthy weight management focuses on balanced nutrition, muscle preservation, and lifestyle changes, not just rapid weight reduction. The national "Weight Management Year" initiative encourages a holistic approach.

中

中国新闻网

Novo Nordisk Launches Wegovy Weight Loss Pill in UAE, First Market Outside US

يتطور

Business·03.06.2026ملخص الذكاء الاصطناعي

Novo Nordisk Launches Wegovy Weight Loss Pill in UAE, First Market Outside US

Novo Nordisk has launched its weight loss pill Wegovy in the United Arab Emirates, marking its first expansion outside the US. The drug, approved for weight management and cardiovascular risk reduction, faces increasing competition in the growing obesity drug market.

CNBC World

يتطور

Business·03.06.2026ملخص الذكاء الاصطناعي

Novo Nordisk launches Wegovy weight loss pill in UAE, first market outside US

Novo Nordisk has launched its weight loss pill Wegovy in the United Arab Emirates, marking its first expansion outside the U.S. market. The drug's approval by the Emirates Drug Establishment follows recent competition from Eli Lilly in the growing obesity drug sector.

CNBC World

3 arrested for selling unapproved diabetes drug 'Mounjaro' as weight loss medication

خبر

02.06.2026ملخص الذكاء الاصطناعي

3 arrested for selling unapproved diabetes drug 'Mounjaro' as weight loss medication

Osaka Prefectural Police have referred three individuals, aged 22-35, to prosecutors for allegedly selling Eli Lilly's diabetes drug 'Mounjaro' without authorization, often marketed as a weight-loss aid on social media. This marks the first such case for the Osaka police and is rare nationwide.

朝

朝日新聞

John Goodman's Dramatic Weight Loss: A Journey of Health and Commitment

ثقافة

02.06.2026ملخص الذكاء الاصطناعي

John Goodman's Dramatic Weight Loss: A Journey of Health and Commitment

Actor John Goodman, 73, has undergone a significant physical transformation, losing over 90 kilos. He attributes the change to health reasons, a gradual process starting in 2007 involving sobriety, a personal trainer, diet changes, and consistent exercise.

20minutos

Trump's Medical Report Declares Him in 'Excellent Health'

سياسة

30.05.2026ملخص الذكاء الاصطناعي

Trump's Medical Report Declares Him in 'Excellent Health'

US President Donald Trump, 79, is declared in 'excellent health' by his physician, Dr. Sean Barbabella, after a routine medical examination, despite recommendations for weight loss and increased physical activity.

Times of India

US President Donald Trump Declared in 'Excellent Health' Ahead of 80th Birthday

سياسة

31.05.2026ملخص الذكاء الاصطناعي

US President Donald Trump Declared in 'Excellent Health' Ahead of 80th Birthday

US President Donald Trump, 79, is deemed in 'excellent health' by his physician, Dr. Sean Barbabella, after a comprehensive medical exam, despite recommendations for weight loss and increased physical activity.

TOI World

CVS Health to Restore Coverage of Eli Lilly's Weight Loss Drugs

خبر

28.05.2026ملخص الذكاء الاصطناعي

CVS Health to Restore Coverage of Eli Lilly's Weight Loss Drugs

CVS Health will restore coverage of Eli Lilly's weight loss injection Zepbound on Oct. 1 and add coverage of its new obesity pill Foundayo on June 1, making both GLP-1 medications co-preferred options on its standard commercial formulary, affecting 25-30 million Americans and boosting Lilly's market position against Novo Nordisk.

CNBC US Markets

Retatrutide: The New Obesity Drug Promising 30% Weight Loss

يتطور

صحة·25.05.2026ملخص الذكاء الاصطناعي

Retatrutide: The New Obesity Drug Promising 30% Weight Loss

Retatrutide, a new obesity drug from Eli Lilly, has shown a 30% weight loss in trials, surpassing previous drugs like Ozempic. It mimics GLP-1 and other hormones, offering benefits beyond weight loss, including anti-inflammatory effects.

El Mundo

Retatrutide: The New Obesity Drug Promising 30% Weight Loss and Broader Health Benefits

يتطور

صحة·24.05.2026ملخص الذكاء الاصطناعي

Retatrutide: The New Obesity Drug Promising 30% Weight Loss and Broader Health Benefits

Retatrutide, a new obesity drug, has shown a 30% weight loss in trials, surpassing previous drugs. Experts highlight its broader benefits beyond weight loss, including reduced inflammation and improved cardiovascular and kidney function, attributing these to its multi-organ receptor action.

El Mundo

Florida's 'Alligator Alcatraz' Immigration Jail Closes Amidst Controversy

يتطور

سياسة·24.05.2026ملخص الذكاء الاصطناعي

Florida's 'Alligator Alcatraz' Immigration Jail Closes Amidst Controversy

Florida's 'Alligator Alcatraz' immigration jail, criticized for inhumane conditions and high costs, is closing. Detainees like Justo Betancourt suffered severe health issues, with doctors suspecting strokes exacerbated by poor medical care and an ankle monitor preventing MRI scans. Governor Ron DeSantis, who championed the facility, is now distancing himself from it.

Guardian International

Nutritionist Explains Why Eating Less Doesn't Always Lead to Weight Loss

صحة

24.05.2026ملخص الذكاء الاصطناعي

Nutritionist Explains Why Eating Less Doesn't Always Lead to Weight Loss

Nutritionist Liao Xin-yi explains that prolonged calorie restriction can lead to weight loss plateaus due to decreased metabolism, muscle loss, increased stress hormones, and reduced NEAT. She advises against extreme calorie deficits and emphasizes adequate protein, maintaining muscle mass, activity, sleep, and stress management.

自

自由时报